Involvement of the melanocortin-1 receptor in acute pain and pain of inflammatory but not neuropathic origin

PLoS ONE

Volumn 5, Issue 9, 2010, Pages 1-10

  Delaney, Ada ^a,b   Keighren, Margaret ^a   Fleetwood Walker, Susan M ^b   Jackson, Ian J ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSAICIN; MELANOCORTIN 1 RECEPTOR; VANILLOID RECEPTOR 1;

ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FEMALE; GENE LOCUS; GENE MUTATION; GENE OVEREXPRESSION; GENETIC VARIABILITY; GENOTYPE; HYPERALGESIA; INFLAMMATION; MALE; MELANOCYTE; MOUSE; NEUROPATHIC PAIN; NOCICEPTION; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; TEMPERATURE; TRANSGENE; ANIMAL; DISEASE MODEL; GENETICS; HUMAN; IMMUNOLOGY; PAIN; TRANSGENIC MOUSE;

AGOUTI; MAMMALIA; MUS;

ANIMALS; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; HYPERALGESIA; MALE; MICE; MICE, TRANSGENIC; PAIN; RECEPTOR, MELANOCORTIN, TYPE 1;

EID: 77958585653     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0012498     Document Type: Article

References (52)

1. Julius D, Basbaum AI (2001) Molecular mechanisms of nociception. Nature 413: 203-210.
2. Dyck PJ (1993) Neuronal atrophy and degeneration predominantly affecting peripheral sensory and autonomic neurons. In: Dyck PJ, Thomas PK, Griffi JW, Low PW, Poduslo JF, eds. Peripheral Neuropathy. Philadelphia: Saunders. Pp 1065-1093.
3. Craft RM (2003) Sex differences in opioid analgesia: ''from mouse to man''. Clin J Pain 19: 175-186.
4. Wiesenfeld-Hallin Z (2005) Sex differences in pain perception. Gend Med 2: 137-145.
5. Berkley KJ (1997) Sex differences in pain. Behav Brain Sci 20: 371-380.
6. Riley JL, III, Robinson ME, Wise EA, Myers CD, Fillingim RB (1998) Sex differences in the perception of noxious experimental stimuli: a meta-analysis. Pain 74: 181-187.
7. Mogil JS, Chesler EJ, Wilson SG, Juraska JM, Sternberg WF (2000) Sex differences in thermal nociception and morphine antinociception in rodents depend on genotype. Neurosci Biobehav Rev 24: 375-389.
8. Kest B, Wilson SG, Mogil JS (1999) Sex differences in supraspinal morphine analgesia are dependent on genotype. J Pharmacol Exp Ther 289: 1370-1375.
9. Mogil JS, Ritchie J, Sotocinal SG, Smith SB, Croteau S, et al. (2006) Screening for pain phenotypes: analysis of three congenic mouse strains on a battery of nine nociceptive assays. Pain 126: 24-34.
10. Wilson SG, Chesler EJ, Hain H, Rankin AJ, Schwarz JZ, et al. (2002) Identification of quantitative trait loci for chemical/inflammatory nociception in mice. Pain 96: 385-391.
11. Furuse T, Miura Y, Yagasaki K, Shiroishi T, Koide T (2003) Identification of QTLs for differential capsaicin sensitivity between mouse strains KJR and C57BL/6. Pain 105: 169-175.
12. Mogil JS, Richards SP, O'Toole LA, Helms ML, Mitchell SR, et al. (1997) Genetic sensitivity to hot-plate nociception in DBA/2J and C57BL/6J inbredmouse strains: possible sex-specific mediation by delta2-opioid receptors. Pain 70: 267-277.
13. Mogil JS, Miermeister F, Seifert F, Strasburg K, Zimmermann K, et al. (2005) Variable sensitivity to noxious heat is mediated by differential expression of the CGRP gene. Proc Natl Acad Sci U S A 102: 12938-12943.
14. Bergeson SE, Helms ML, O'Toole LA, Jarvis MW, Hain HS, et al. (2001) Quantitative trait loci influencing morphine antinociception in four mapping populations. Mamm Genome 12: 546-553.
15. Giros B, Pohl M, Rochelle JM, Seldin MF (1995) Chromosomal localization of opioid peptide and receptor genes in the mouse. Life Sci 56: PL369-PL375.
16. Kavaliers M, Choleris E (1997) Sex differences in N-methyl-D-aspartate involvement in kappa opioid and non-opioid predator-induced analgesia in mice. Brain Res 768: 30-36.
17. Mogil JS, Wilson SG, Chesler EJ, Rankin AL, Nemmani KV, et al. (2003) The melanocortin-1 receptor gene mediates female-specific mechanisms of analgesia in mice and humans. Proc Natl Acad Sci U S A 100: 4867-4872.
18. Xia Y, Wikberg JE, Chhajlani V (1995) Expression of melanocortin 1 receptor in periaqueductal gray matter. Neuroreport 6: 2193-2196.
19. Basbaum AI Fields HL (1984) Endogenous pain control systems: brainstem spinal pathways and endorphin circuitry. Annu Rev Neurosci 7: 309-338.
20. Mogil JS, Ritchie J, Smith SB, Strasburg K, Kaplan L, et al. (2005) Melanocortin-1 receptor gene variants affect pain and mu-opioid analgesia in mice and humans. J Med Genet 42: 583-587.
21. Liem EB, Joiner TV, Tsueda K, Sessler DI (2005) Increased sensitivity to thermal pain and reduced subcutaneous lidocaine efficacy in redheads. Anesthesiology 102: 509-514.
22. Mountjoy KG, Mortrud MT, Low MJ, Simerly RB, Cone RD (1994) Localization of the melanocortin-4 receptor (MC4-R) in neuroendocrine and autonomic control circuits in the brain. Mol Endocrinol 8: 1298-1308.
23. Miller MW, Duhl DM, Vrieling H, Cordes SP, Ollmann MM, et al. (1993) Cloning of the mouse agouti gene predicts a secreted protein ubiquitously expressed in mice carrying the lethal yellow mutation. Genes Dev 7: 454-467.
24. Becher E, Mahnke K, Brzoska T, Kalden DH, Grabbe S, et al. (1999) Human peripheral blood-derived dendritic cells express functional melanocortin receptor MC-1R. Ann N Y Acad Sci 885: 188-195.
25. Bhardwaj R, Becher E, Mahnke K, Hartmeyer M, Schwarz T, et al. (1997) Evidence for the differential expression of the functional alpha-melanocytestimulating hormone receptor MC-1 on human monocytes. J Immunol 158: 3378-3384.
26. Catania A, Rajora N, Capsoni F, Minonzio F, Star RA, et al. (1996) The neuropeptide alpha-MSH has specific receptors on neutrophils and reduces chemotaxis in vitro. Peptides 17: 675-679.
27. Elitt CM, Malin SA, Koerber HR, Davis BM, Albers KM (2008) Overexpression of artemin in the tongue increases expression of TRPV1 and TRPA1 in trigeminal afferents and causes oral sensitivity to capsaicin and mustard oil. Brain Res 1230: 80-90.
28. Jackson IJ, Budd PS, Keighren M, McKie L (2007) Humanized MC1R transgenic mice reveal human specific receptor function. Hum Mol Genet 16: 2341-2348.
29. Yaswen L, Diehl N, Brennan MB, Hochgeschwender U (1999) Obesity in the mouse model of pro-opiomelanocortin deficiency responds to peripheral melanocortin. Nat Med 5: 1066-1070.
30. Slominski A, Plonka PM, Pisarchik A, Smart JL, Tolle V, et al. (2005) Preservation of eumelanin hair pigmentation in proopiomelanocortin-deficient mice on a nonagouti (a/a) genetic background. Endocrinology 146: 1245-1253.
31. Krude H, Biebermann H, Luck W, Horn R, et al. (1998) Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans. Nat Genet 19: 155-157.
32. Krude H, Biebermann H, Schnabel D, Tansek MZ, Theunissen P, et al. (2003) Obesity due to proopiomelanocortin deficiency: three new cases and treatment trials with thyroid hormone and ACTH4-10. J Clin Endocrinol Metab 88: 4633-4640.
33. Lu D, Willard D, Patel IR, Kadwell S, Overton L, et al. (1994) Agouti protein is an antagonist of the melanocyte-stimulating-hormone receptor. Nature 371: 799-802.
34. Ollmann MM, Lamoreux ML, Wilson BD, Barsh GS (1998) Interaction of Agouti protein with the melanocortin 1 receptor in vitro and in vivo. Genes Dev 12: 316-330.
35. Suzuki I, Tada A, Ollmann MM, Barsh GS, Im S, et al. (1997) Agouti signaling protein inhibits melanogenesis and the response of human melanocytes to alphamelanotropin J Invest Dermatol 108: 838-842.
36. Sakai C, Ollmann M, Kobayashi T, Abdel-Malek Z, Muller J, et al. (1997) Modulation of murine melanocyte function in vitro by agouti signal protein. EMBO J 16: 3544-3552.
37. Bennett GJ, Xie YK (1988) A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 33: 87-107.
38. Dubuisson D, Dennis SG (1977) The formalin test: a quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats. Pain 4: 161-174.
39. Tjolsen A, Berge OG, Hunskaar S, Rosland JH, Hole K (1992) The formalin test: an evaluation of the method. Pain 51: 5-17.
40. Sufka KJ, Watson GS, Nothdurft RE, Mogil JS (1998) Scoring the mouse formalin test: validation study. Eur J Pain 2: 351-358.
41. Bellasio S, Nicolussi E, Bertorelli R, Reggiani A (2003) Melanocortin receptor agonists and antagonists modulate nociceptive sensitivity in the mouse formalin test. Eur J Pharmacol 482: 127-132.
42. Zvejniece L, Muceniece R, Krigere L, Dambrova M, Klusa VZ (2006) The differential influences of melanocortins on nociception in the formalin and tail flick tests. Pharmacol Biochem Behav 85: 287-291.
43. Starowicz K, Bilecki W, Sieja A, Przewlocka B, Przewlocki R (2004) Melanocortin 4 receptor is expressed in the dorsal root ganglions and downregulated in neuropathic rats. Neurosci Lett 358: 79-82.
44. Kishi T, Aschkenasi CJ, Lee CE, Mountjoy KG, Saper CB, et al. (2003) Expression of melanocortin 4 receptor mRNA in the central nervous system of the rat. J Comp Neurol 457: 213-235.
45. Bertorelli R, Fredduzzi S, Tarozzo G, Campanella M, Grundy R, et al. (2005) Endogenous and exogenous melanocortin antagonists induce anti-allodynic effects in a model of rat neuropathic pain. Behav Brain Res 157: 55-62.
46. Vrinten DH, Gispen WH, Groen GJ, Adan RA (2000) Antagonism of the melanocortin system reduces cold and mechanical allodynia in mononeuropathic rats. J Neurosci 20: 8131-8137.
47. Starowicz K, Mousa SA, Obara I, Chocyk A, Przewlocki R, et al. (2009) Peripheral antinociceptive effects of MC4 receptor antagonists in a rat model of neuropathic pain - a biochemical and behavioral study. Pharmacol Rep 61: 1086-1095.
48. anabe K, Gamo K, Aoki S, Wada K, Kiyama H (2007) Melanocortin receptor 4 is induced in nerve-injured motor and sensory neurons of mouse. J Neurochem 101: 1145-1152.
49. Simons CT, Dessirier JM, Jinks SL, Carstens E (2001) An animal model to assess aversion to intra-oral capsaicin: increased threshold in mice lacking substance P. Chem Senses 26: 491-497.
50. Caterina MJ, Schumacher MA, Tominaga M, Rosen TA, Levine JD, et al. (1997) The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature 389: 816-824.
51. Ji RR, Samad TA, Jin SX, Schmoll R, Woolf CJ (2002) p38 MAPK activation by NGF in primary sensory neurons after inflammation increases TRPV1 levels and maintains heat hyperalgesia. Neuron 36: 57-68.
52. Hargreaves K, Dubner R, Brown F, Flores C, Joris J (1988) A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 32: 77-88.